IMAGE: University of Houston researcher Sanghyuk Chung, is examining the role of estrogen in cervical cancer and defining molecular targets for treatment. view more
HOUSTON, March 1, 2018 – Two University of Houston researchers, working to find cancer cures, received grants from the Cancer Prevention & Research Institute of Texas (CPRIT), the organization that funds groundbreaking cancer research and prevention programs in the state.
CPRIT awarded $1,173,420 to Navin Varadarajan, associate professor of chemical and biomolecular engineering, to improve effectiveness of T-cell immunotherapy and $811,617 to Sanghyuk Chung, associate professor of biology and biochemistry, to define molecular targets for the treatment of cervical cancer.
Sanghyuk Chung, Cervical Cancer
Although cervical cancer is the fourth leading cause of cancer death in women worldwide, there has been little progress in the treatment of it over the past decade. Chung is set to change that as he uses his CPRIT award to delve into a little-researched topic – the role of estrogen in the development of cervical cancer.
“It is clearly demonstrated that human papillomavirus (HPV) is required for the development of cervical cancer, but evidence indicates that other co-factors are required for cervical cancer,” said Chung.
Suspect number one, he said, is
Article originally posted at